Petra Olejnikova

Dr. Petra Olejnikova

Department of Biochemistry and Microbiology, The Slovak University of Technology in Bratislava, Bratislava, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Microbiological Research
Verified
Journal Article
Closed access
JVJán Víglaš
Ján Víglaš
POPetra Olejnikova
Petra Olejnikova

KLKristína Lépesová
Kristína Lépesová
POPetra Olejnikova
Petra Olejnikova
Tomáš MackuľakTomáš Mackuľak
Tomáš Mackuľak
KCKlára Cverenkárová
Klára Cverenkárová
MKMonika Krahulcová
Monika Krahulcová
LBLucia Bírošová
Lucia Bírošová
This work compares the prevalence of antibiotic resistant coliform bacteria in hospital wastewater effluents in Slovak (SR) and Czech Republic (ČR). It also describes selected antibiotic resistant isolates in view of resistance mechanism and virulence factor. The highest number of multidrug resistant bacteria was detected in samples from the hospital in Valašské Meziříčí (ČR). More than half of resistant isolates showed multidrug resistance phenotype as well as strong ability to form biofilm. In 42% of isolates efflux pump overproduction was detected together with tetA and tetE genes. The production of extended-spectrum β-lactamases in coliform isolates was encoded mainly by blaTEM, blaCTX-M-2 and blaCTX-M-8/25 genes. About 62% of resistants contained a combination of two or more extended spectrum beta-lactamases (ESBL) genes. Our results strengthen the fact that hospital effluents are a source of multidrug resistant bacteria which can spread their resistance genes to other bacteria in wastewater treatment plants (WWTPs). Accordingly, hospital wastewater should be better treated before it enters urban sewerage.

1 November 2005 in Research in Microbiology
Verified
Journal Article
Closed access
RPRichard Pokorný
Richard Pokorný
POPetra Olejnikova
Petra Olejnikova
MBMiroslav Balog
Miroslav Balog
PZPeter Zifčák
Peter Zifčák
UHUdo Hölker
Udo Hölker
LVL'Udovít Varečka
L'Udovít Varečka

1 September 2018 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
KLKristína Lépesová
Kristína Lépesová
LKLucia Kraková
Lucia Kraková
DPDomenico Pangallo
Domenico Pangallo
AVAlžbeta Vavreková
Alžbeta Vavreková
POPetra Olejnikova
Petra Olejnikova
LBLucia Birošová
Lucia Birošová

1 January 2014 in Scientia Pharmaceutica
Verified
Journal Article
Open access
POPetra Olejnikova
Petra Olejnikova
LSL'Ubomír Svorc
L'Ubomír Svorc
DODenisa Olšovská
Denisa Olšovská
APAnna Panáková
Anna Panáková
ZVZuzana Vihonská
Zuzana Vihonská
SMStefan Marchalín
Stefan Marchalín
The antimicrobial activity of 3-methyl-5-isopropyl (or ethyl) 6-methyl-4-nitrophenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives was evaluated. Prokaryotes (bacteria) appeared to be more sensitive to their antimicrobial activity than were eukaryotes (filamentous fungi). The best antibacterial activity was shown by derivative 33, which was able to inhibit the growth of Mycobacterium smegmatis (MIC33 = 9 μg.ml(-1)), Staphylococcus aureus (MIC33 = 25 μg.ml(-1)), and Escherichia coli (MIC33 = 100 μg.ml(-1)). In addition, derivative 4 demonstrated its antibacterial power on the acid-fast bacterial species M. smegmatis and on Gram-positive S. aureus. Focusing on the structure-activity relationship, it appears that the increase in the substituent bulk at the C2 position improved the antibacterial activity of the set of compounds studied. Derivatives 33 and 4, carrying 2-cyano-3-oxo-3-phenylprop-1-en-1-yl and allyliminomethyl groups, respectively, showed significantly higher inhibition activities on all tested microorganisms in comparison with the rest of the derivatives. This enhancement was also in good correlation with different log P values (lipophilicity parameter).

1 January 2021 in Research in Microbiology
Verified
Journal Article
Closed access
JVJán Víglaš
Ján Víglaš
POPetra Olejnikova
Petra Olejnikova